Table 2: Changes in fasting blood glucose (BGf, mg/dl), plasma insulin level (μU/ml), HOMA-IR, fibrinogen level (FB, μgm/ml) and interleukin6 (IL6) (pg/ml)in the different studied groups.
Rat group | BGf (mg/dl) | Insulin level (μU/ml) | HOMA-IR | Fibrinogen level (μgm/ml) | IL6 (pg /ml) |
Control group (n = 13) |
120.46 ± 8.08 |
3.27 ± 0.11 |
0.98 ± 0.11 |
35.88 ± 3.22 |
122.92 2.81 |
MS (n = 12) P1 |
119.08 ± 9.4 NS |
3.2 ± 0.07 NS |
0.94 ± 0.08 NS |
32.76 ± 2.69 NS |
164.54 4.76 < 0.001 |
MSE (n = 10) P1 P2 |
114.1 ± 3.43 NS NS |
3.2 ± 0.08 NS NS |
0.9 ± 0.04 NS NS |
37.03 ± 1.67 NS NS |
136.6 1.58 < 0.02 < 0.001 |
MSS (n = 13) P1 P2 P3 |
110.6 ± 7.47 (n = 13) NS NS NS |
4.08 ± 0.17 (n = 13) < 0.001 < 0.001 < 0.001 |
1.11 ± 0.09 (n = 13) NS NS NS |
34.61 ± 2.93 (n = 12) NS NS NS |
139.72 1.96 (n = 11) < 0.002 < 0.001 NS |
All results are expressed as mean ± SEM
P1: Significance by LSD at P < 0.05 from control group.
P2: Significance by LSD at P < 0.05 from metabolic syndrome group.
P3: Significance by LSD at P < 0.05 from metabolic syndrome swim- exercised group.
NS: not significant. n: is the number of rats.